ATE95424T1 - Durch ''site-directed'' mutagenese modifzierte glukoprotein-hormone und verfahren zu deren verwendung. - Google Patents

Durch ''site-directed'' mutagenese modifzierte glukoprotein-hormone und verfahren zu deren verwendung.

Info

Publication number
ATE95424T1
ATE95424T1 AT88312143T AT88312143T ATE95424T1 AT E95424 T1 ATE95424 T1 AT E95424T1 AT 88312143 T AT88312143 T AT 88312143T AT 88312143 T AT88312143 T AT 88312143T AT E95424 T1 ATE95424 T1 AT E95424T1
Authority
AT
Austria
Prior art keywords
hormones
glycoprotein hormones
site
directed mutagenesis
glucoprotein
Prior art date
Application number
AT88312143T
Other languages
English (en)
Inventor
Scott C Chappel
Edward G Bernstine
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22471965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE95424(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE95424T1 publication Critical patent/ATE95424T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/11—Gonadotropin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT88312143T 1987-12-21 1988-12-21 Durch ''site-directed'' mutagenese modifzierte glukoprotein-hormone und verfahren zu deren verwendung. ATE95424T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/136,236 US5260421A (en) 1987-12-21 1987-12-21 Site-directed mutagenesis modified glycoprotein hormones
EP88312143A EP0322226B2 (de) 1987-12-21 1988-12-21 Durch "site-directed" Mutagenese modifzierte Glukoprotein-Hormone und Verfahren zu deren Verwendung

Publications (1)

Publication Number Publication Date
ATE95424T1 true ATE95424T1 (de) 1993-10-15

Family

ID=22471965

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88312143T ATE95424T1 (de) 1987-12-21 1988-12-21 Durch ''site-directed'' mutagenese modifzierte glukoprotein-hormone und verfahren zu deren verwendung.

Country Status (9)

Country Link
US (3) US5260421A (de)
EP (1) EP0322226B2 (de)
JP (1) JP2525048B2 (de)
AT (1) ATE95424T1 (de)
CA (1) CA1341284C (de)
DE (1) DE3884776T3 (de)
ES (1) ES2059545T5 (de)
GR (1) GR3032307T3 (de)
HK (1) HK143395A (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260421A (en) * 1987-12-21 1993-11-09 Applied Research Systems Ars Holding N.V. Site-directed mutagenesis modified glycoprotein hormones
US5635475A (en) * 1987-12-21 1997-06-03 Applied Research Systems Ars Holding N.V. Site-directed mutagenesis modified glycoprotein hormones and methods of use
US5444167A (en) * 1993-07-07 1995-08-22 Wallac Oy Variant luteinizing hormone encoding DNA
JPH09508114A (ja) * 1994-01-20 1997-08-19 アクゾ・ノベル・エヌ・ベー 卵胞刺激活性を有する糖タンパク質イソ型新規組成物
US6238890B1 (en) * 1994-02-18 2001-05-29 Washington University Single chain forms of the glycoprotein hormone quartet
US5919758A (en) * 1994-03-22 1999-07-06 Beth Israel Deaconess Medical Center Modified polypeptides with altered biological activity
US5747446A (en) * 1994-03-22 1998-05-05 Beth Israel Deaconess Medical Center Modified polypeptides with increased biological activity
US5580853A (en) * 1994-03-22 1996-12-03 New England Deaconess Hospital Modified polypeptides with increased biological activity
AU2603995A (en) * 1994-05-25 1995-12-18 University Of Nebraska Board Of Regents Biologically active glycoprotein hormones produced in procaryotic cells
FR2768627B1 (fr) * 1997-09-19 2000-03-24 Agronomique Inst Nat Rech Medicament veterinaire contenant de la choriogonadotropine equine modifiee pour induire l'ovulation chez la jument et stimuler la production de testosterone chez l'etalon
US7198954B1 (en) * 1999-02-03 2007-04-03 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by hCG assay
US6500627B1 (en) * 1998-02-03 2002-12-31 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by HCG assay
US6927034B2 (en) * 1998-02-03 2005-08-09 The Trustees Of Columbia University In The City Of New York Methods for detecting trophoblast malignancy by HCG assay
WO2001025277A1 (en) * 1999-10-07 2001-04-12 Maxygen Aps Single-chain antagonist polypeptides
US7081446B2 (en) 2002-01-31 2006-07-25 The Trustees Of Columbia University In The City Of New York Long-acting follicle stimulating hormone analogues and uses thereof
US20050221443A1 (en) * 2003-01-06 2005-10-06 Xencor, Inc. Tumor necrosis factor super family agonists
US20050130892A1 (en) * 2003-03-07 2005-06-16 Xencor, Inc. BAFF variants and methods thereof
US20060014248A1 (en) * 2003-01-06 2006-01-19 Xencor, Inc. TNF super family members with altered immunogenicity
US7553930B2 (en) * 2003-01-06 2009-06-30 Xencor, Inc. BAFF variants and methods thereof
CN103930134B (zh) 2011-07-18 2016-12-21 阿茨生物股份有限公司 长效促黄体激素(lh)化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840896A (en) * 1983-11-02 1989-06-20 Integrated Genetics, Inc. Heteropolymeric protein
DE3787020T2 (de) * 1986-05-06 1993-12-16 Genetics Inst Herstellung von m-csf.
US4879227A (en) * 1986-05-06 1989-11-07 Genetics Institute, Inc. Production of a recombinant human colony stimulating factor
US4868119A (en) * 1986-12-11 1989-09-19 Genetics Institute, Inc. Hematopoietic growth factors
JPS63304997A (ja) * 1987-06-08 1988-12-13 Kyowa Hakko Kogyo Co Ltd 魚類の生殖腺刺激ホルモン遺伝子
US5260421A (en) * 1987-12-21 1993-11-09 Applied Research Systems Ars Holding N.V. Site-directed mutagenesis modified glycoprotein hormones
AU648020B2 (en) * 1989-02-21 1994-04-14 Washington University Modified forms of reproductive hormones

Also Published As

Publication number Publication date
DE3884776D1 (de) 1993-11-11
EP0322226A3 (en) 1990-06-13
US5352779A (en) 1994-10-04
JP2525048B2 (ja) 1996-08-14
HK143395A (en) 1995-09-15
US5260421A (en) 1993-11-09
CA1341284C (en) 2001-08-14
EP0322226B2 (de) 1999-11-10
EP0322226B1 (de) 1993-10-06
DE3884776T3 (de) 2000-06-21
DE3884776T2 (de) 1994-02-10
EP0322226A2 (de) 1989-06-28
US5986068A (en) 1999-11-16
JPH022384A (ja) 1990-01-08
GR3032307T3 (en) 2000-04-27
ES2059545T5 (es) 2000-05-01
ES2059545T3 (es) 1994-11-16

Similar Documents

Publication Publication Date Title
ATE95424T1 (de) Durch ''site-directed'' mutagenese modifzierte glukoprotein-hormone und verfahren zu deren verwendung.
ATE174382T1 (de) Retrovirus aus der hiv-gruppe und dessen verwendung
EP0355460A3 (de) Stabilisierung von Somatotropinen durch Modifikation von Cystein-Resten durch orts-spezifische Mutagenese oder chemische Derivatisierung
CA2204616A1 (en) Ppar gamma antagonists for treating obesity
ATE184019T1 (de) Monoklonale antikörper gegen rezeptor-induzierte bindungsstellen
DK0751992T3 (da) Karendotelvækstfaktor 2
PT998288E (pt) Composicoes contendo capsaicina ou analogos de capsaicina e um anestesico local
EP0577605A4 (de)
PT639979E (pt) Ligando para o receptor c-kit e metodos para a sua utilizacao
DK0669979T3 (da) C-C CKR-1, kemokinreceptor
DE59101889D1 (de) Variante cd44-oberflächenproteine, diese kodierende dna-sequenzen, antikörper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie.
WO1995019570B1 (en) Antagonists to insulin receptor tyrosine kinase inhibitor
KR980002066A (ko) 변이형 인간 성장호르몬 및 그의 용도
ATE314392T1 (de) Einzelketten-gonadotropin
GR3025698T3 (en) NOVEL GABAa RECEPTOR SUBTYPES AND METHODS FOR SCREENING DRUG COMPOUNDS USING IMIDAZOQUINOXALINES AND PYRROLOPYRIMIDINES TO BIND TO GABAa RECEPTOR SUBTYPES.
Potter et al. [Pro34] neuropeptide Y selectively identifies postjunctional-mediated actions of neuropeptide Y in vivo in rats and dogs
ATE115409T1 (de) Glykoprotein-hormonrezeptor-moleküle.
Ulloa-Aguirre et al. Effects of gonadotrophin-releasing hormone, recombinant human activin-A and sex steroid hormones upon the follicle-stimulating isohormones secreted by rat anterior pituitary cells in culture
EP0315118A3 (de) Endothelin kodierendes DNA und dessen Verwendung
ATE242641T1 (de) Behandlung von stressinduzierten hautkrankheiten unter verwendung von corticoliberin (crh)- antagonisten und inhibitoren der hautmastzell- degranulation
ATE103989T1 (de) Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung.
DE59109261D1 (de) Von proteinen des hepatitis c-virus abgeleitete polypeptide und deren verwendung
EP0659217A4 (de) KLONIERUNG UND EXPRESSION VON DEM -g(b)APP-C100 REZEPTOR.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time